Home/Critical Appraisal
Critical Appraisal

Allocation Concealment

EM FINAL EXAMS Critical Appraisal · Trial methods Allocation Concealment Hiding the UPCOMING allocation from whoever enrols and assigns patients, so they cannot subvert randomisation. Definition Keeping the next treatment assignment unknown to recruiters and clinicians until the moment a patient is irreversibly entered. It prevents anyone from steering sicker or more favourable patients into […]

EM FINAL EXAMS Critical Appraisal · Trial methods

Allocation Concealment

Hiding the UPCOMING allocation from whoever enrols and assigns patients, so they cannot subvert randomisation.

Definition

Keeping the next treatment assignment unknown to recruiters and clinicians until the moment a patient is irreversibly entered. It prevents anyone from steering sicker or more favourable patients into a preferred arm. Achieved by central/remote randomisation, sequentially-numbered opaque sealed envelopes, or pharmacy-controlled packs. It happens at allocation — distinct from blinding, which happens after.

The picture

The recruiter is committed before the arm is known — so they cannot cherry-pick who goes where.

What it shows

A barrier between the randomisation list and the person enrolling patients. The allocation is only released once a patient is irreversibly entered — so selection cannot be gamed at the point of entry.

How to read it

Trace one patient: the recruiter decides to enrol and commits before the arm is disclosed. With central randomisation or a sealed opaque pack there is no way to peek ahead. Poor methods — an open list, or a translucent envelope held to the light — let the recruiter see what’s next and decline or delay an “inconvenient” patient.

Why it matters

Broken concealment lets baseline prognosis differ between arms before treatment even starts — that is selection bias, and it inflates apparent effects. Trials with inadequate or unclear concealment report exaggerated treatment effects on average, so it is a core risk-of-bias domain.

Key
  • Concealment = before/at allocation → prevents selection bias
  • Blinding = after allocation → prevents performance/detection bias
  • Gold standard: central/remote randomisation or sequentially-numbered opaque sealed envelopes
Pitfall
Pitfall Do not confuse allocation concealment (before/at allocation, stops recruiters subverting who goes where) with blinding (after allocation, stops biased care and outcome assessment). Poor concealment is one of the strongest drivers of inflated effect estimates.
emfinalexams.com · FRCEM / MRCEM revision
EM trial in the wild

CRASH-2 (Lancet 2010) — 20,211 trauma patients, TXA vs placebo. Allocation was concealed: treatment packs were identical apart from a number, with central telephone randomisation (Oxford CTSU) where practicable and a sequentially-numbered local pack system otherwise, so the recruiter never knew the next assignment. Concealment is not blinding: here the identical packs delivered both — recruiters could not subvert entry, and staff could not tell TXA from placebo afterwards.

Examiner traps
  • Equating allocation concealment with blinding — concealment is before/at allocation, blinding is after.
  • Accepting “sealed envelopes” without checking they were opaque, sequentially numbered and tamper-evident.
  • Missing that broken concealment causes selection bias and inflates the effect estimate.
Quick check

What does allocation concealment prevent?
Answer: Selection bias — it stops the people recruiting and assigning patients from foreseeing the next allocation and subverting who goes into which arm.

Related cards

Ready to build your plan? EMF Premium gives you all 40,000+ questions, 20 mocks and 1,215 OSCE stations from £29/month — or a one-off 3- or 6-month pass.

Share
0
    0
    Your Cart
    Your cart is emptyReturn to Shop